[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Hutom Corp\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":46},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100582813","a-multicenter-study-of-rus-ne-100582813",false,"NCT06868186","A Multicenter Study of RUS NE","A Multicenter, Randomized, Parallel-group Study to Evaluate Efficacy of Surgical Navigation System 'RUS NE' in Patient Underwent Robot-assisted Partial Nephrectomy","Inclusion Criteria:\n\n* Individuals who were diagnosed with renal tumor and undergo robot-assisted partial nephrectomy\n* The diameter of renal tumor is 7cm or below\n* Individuals aged between 19 and 80\n* Individuals who, before participating in the clinical trial, undergo an interview in a separate place, understand sufficient explanation of the purpose and content of the trial, and voluntarily sign informed consent form\n\nExclusion Criteria:\n\n* Individuals with solitary kidney or horseshoe kidney\n* Individuals undergo bilateral nephrectomy\n* Individuals undergo operation other than partial nephrecotmy\n* Individuals with a history of abdominal surgery and are expected to have severe intra-abdominal adhesion influencing the surgical outcomes\n* Individuals with severe chronic kidney disease (eGFR \\\u003C 45, calculated with EPI-CKI equation)\n* Individuals with American society of anesthesiologists physical status classification (ASA) IV-VI\n* Individuals with a history of psychosis, alcohol abuse or are expected not to adhere to the schedule of the clinical study\n* Individuals who were participated in other clinical study within 4 weeks of screening\n* Individuals who are thought to be inappropriate to participate to the clinical trial by the investigators","ALL","19 Years","80 Years",{"count":20,"type":21},204,"ESTIMATED","INTERVENTIONAL",[24],"NA","This sponsor-initiated, randomized controlled clinical trial aims to demonstrate the clinical efficacy of RUS NE Surgical Navigation System in patients undergoing robotic-assisted partial nephrectomy. The trial will compare the experimental group (n=102) using RUS NE with a control group (n=102), aiming to show an 10% reduction in operation time. The study will involve 6 medical centers in South Korea in patient recruitment and evaluate the clinical efficacy and feasibility of the software, which has been shown to be reliable in previous studies.\n\n* Investigational Medical Device: RUS NE (Endoscopic Imaging Treatment Planning Software)\n* Clinical Trial duration: 24 months from IRB approval -Target number of subjects: Total of 204 participants",[27],"Renal Tumors",[29,30,31,32],"renal tumor","robot assisted partial nephrectomy","3D model","surgical navigation","RECRUITING","2025-09-10",{"date":36,"type":37},"2025-09-11","ACTUAL",{"date":39,"type":37},"2025-04-29",{"date":41,"type":21},"2026-04-30",{"name":43,"class":44},"Hutom Corp","INDUSTRY",4,""]